Aehr Test Systems Stock Jumps 26% After Record Quarter and Raised Revenue Outlook
The company reported first-quarter fiscal 2027 revenue of $33.0 million and raised its full-year revenue forecast to $150 million.

Key points
- Aehr shares rose 26.5% on Tuesday after record first-quarter revenue and a raised fiscal 2027 outlook in an 8-K press release
- Q1 fiscal 2027 revenue was $33.0 million, up 200% year over year
- Full-year revenue outlook raised to $150 million
- Bookings of $46.7 million; effective backlog $109.3 million
Aehr Test Systems (Nasdaq: AEHR) rose 26.5% on Tuesday, closing at $65.11 from a previous close of $51.47, as the S&P 500 ETF (SPY) gained 0.30%. Trading volume was about 3.2 times its normal level. The move followed an 8-K filed the previous afternoon, which furnished a press release reporting record first-quarter results.
Record revenue and profit
The press release reported revenue of $33.0 million for the first quarter ended September 25, 2026, up 200% from $11.0 million a year earlier and 75% from the prior quarter. GAAP net income was $7.2 million, or $0.21 per diluted share, compared with a net loss of $2.1 million a year earlier. Non-GAAP net income was $9.4 million, or $0.28 per diluted share.
Raised outlook and backlog
Aehr raised its fiscal 2027 revenue outlook to $150 million, from a previous range of $130 million to $150 million. The company also expects non-GAAP net income of at least 20% of revenue. Bookings were $46.7 million, a book-to-bill ratio of about 1.4, and effective backlog reached $109.3 million as of November 1, 2026.
Customer developments
The press release said a major supplier of AI accelerators, CPUs and network processors decided to buy a fully configured FOX-XP wafer-level burn-in test cell for installation at an outsourcing partner in Taiwan, with installation planned for early calendar 2027. Aehr also said it is shipping more than a dozen Sonoma package-level burn-in systems per month for a lead hyperscale customer. The company did not disclose whether the customer developments were the direct trigger for the share move.
Sources
Written with AI from SEC filings and market data, and checked against those sources before publishing. Our editorial standards.
Other stock movers this week
- Idexx Laboratories Stock Jumps 22% After Third-Quarter Results and Raised 2026 Guidance · IDXX · Nov. 2, 2026
- Community Health Systems Stock Falls 12% After UBS Cuts Price Target · CYH · Nov. 2, 2026
- Kosmos Energy Stock Falls 13% on Monday; No Reason for the Move Was Given · KOS · Nov. 2, 2026
- Frontier Group Stock Rises 15% After UBS Raises Its Price Target · ULCC · Nov. 2, 2026
Latest on Zintick
- Enhanced Group Sets 1-for-10 Reverse Stock Split, Effective Oct. 29 · ENHA · Nov. 3, 2026
- Weyco Group Declares $2.00 Special Cash Dividend, Payable Jan. 8, 2027 · WEYS · Nov. 3, 2026
- Rockwell Medical to Buy Vantive's Hemodialysis Business for $125 Million Plus Debt-Style Financing · RMTI · Nov. 3, 2026
- AMD Tops Revenue Estimates at $13.4 Billion as Data Center Sales Jump 97% · AMD · Nov. 3, 2026
- Arista Networks Beats Estimates With $3.66 Billion Revenue, Up 58.5% · ANET · Nov. 3, 2026
More on Aehr Test Systems
AEHR page →Filings, figures and price history are on the Aehr Test Systems page.